CPR-total (TAFI and activated TAFI) levels in plasma/serum of hemophiliacs

Microbiology and Immunology

Volumn 44, Issue 1, 2000, Pages 77-78

  Guo, Xiaoyan ^a   Okada, Noriko ^a   Okada, Hidechika ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Arginine carboxypeptidase (CPR); Hemophiliacs; HIV 1 infection; Thrombin activable fibrinolysis inhibitor (TAFI proCPR)

Indexed keywords

ARGININE CARBOXYPEPTIDASE; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033957038     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2000.tb01249.x     Document Type: Article

References (13)

1. Bajzar, L., Morser, J., and Nesheim, M. 1996. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271: 16603-16608.
2. Bajzar, L., Manuel, R., and Nesheim, M.E. 1995. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 270: 14477-14484.
3. Broze, G.J., Jr., and Higuchi, D.A. 1996. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood 88: 3815-3823.
4. Campbell, W., and Okada, H. 1989. An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem. Biophys. Res. Commun. 162: 933-939.
5. Campbell, W., Yonezu, K., Shinohara, T., and Okada, H. 1990. An arginine carboxypeptidase generated during coagulation is diminished or absent in patients with rheumatoid arthritis. J. Lab. Clin. Med. 115: 610-612.
6. Eaton, D.L., Malloy, B.E., Tsai, S.P., Henzel, W., and Drayna, D. 1991. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem. 266: 21833-21838.
7. Erdös, E.G., and Sloane, E.M. 1962. An enzyme in human plasma that inactivates bradykinin and kallidins. Biochem. Pharm. 11: 585-592.
8. Guo, X., Morioka, A., Kaneko, Y., Okada, N., Obata, K., Nomura, T., Campbell, W., and Okada, H. 1999. Arginine carboxypeptidase (CPR) in human plasma determined with sandwich ELISA. Microbiol. Immunol. 43: 691-698.
9. Hendriks, D., Wang, W., Scharpe, S., Lommaert, M.P., and Sande, M.V. 1990. Purification and characterization of a new arginine carboxypeptidase in human serum. J. Clin. Chem. Clin. Biophys. Acta 1034: 86-92.
10. Miles, L.A., Dahlberg, C.M., Plescia, J., Felez, J., Kato, K., and Plow, E.F. 1991. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 30: 1682-1691.
11. Pannell, R., Black, J., and Gurewich, V. 1988. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. J. Clin. Invest. 81: 853-859.
12. Redlitz, A., Tan, A.K., Eaton, D.L., and Plow, E.F. 1995. Plasma carboxypeptidases as regulators of the plasminogen system. J. Clin. Invest. 96: 2534-2538.
13. Shinohara, T., Sakurada, C., Suzuki, T., Takeuchi, O., Campbell, W., Ikeda, S., Okada, N., and Okada, H. 1994. Pro-Carboxypeptidase R cleaves bradykinin following activation. Int. Arch. Allergy Immunol. 103: 400-404.